Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Zepp Health (ZEPP) EBITDA Margin (2016 - 2025)

Zepp Health has reported EBITDA Margin over the past 10 years, most recently at 4.55% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 1047.0% year-over-year to 4.55%; the TTM value through Dec 2025 reached 11.29%, up 1458.0%, while the annual FY2025 figure was 3.42%, 2245.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 4.55% at Zepp Health, down from 1.17% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 3.9% in Q2 2021 and troughed at 47.68% in Q1 2025.
  • A 5-year average of 12.17% and a median of 8.3% in 2022 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: tumbled -3133bps in 2024 and later soared 2836bps in 2025.
  • Year by year, EBITDA Margin stood at 0.61% in 2021, then plummeted by -1193bps to 6.62% in 2022, then soared by 111bps to 0.75% in 2023, then plummeted by -2090bps to 15.01% in 2024, then surged by 70bps to 4.55% in 2025.
  • Business Quant data shows EBITDA Margin for ZEPP at 4.55% in Q4 2025, 1.17% in Q3 2025, and 10.27% in Q2 2025.